GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (NSE:THYROCARE) » Definitions » Scaled Net Operating Assets

Thyrocare Technologies (NSE:THYROCARE) Scaled Net Operating Assets : N/A (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Thyrocare Technologies's operating assets for the quarter that ended in Mar. 2025 was ₹4,998 Mil. Thyrocare Technologies's operating liabilities for the quarter that ended in Mar. 2025 was ₹1,210 Mil. Thyrocare Technologies's Total Assets for the quarter that ended in Dec. 2024 was ₹0 Mil. Therefore, Thyrocare Technologies's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2025 was N/A.


Thyrocare Technologies Scaled Net Operating Assets Historical Data

The historical data trend for Thyrocare Technologies's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thyrocare Technologies Scaled Net Operating Assets Chart

Thyrocare Technologies Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.68 0.75 0.69 0.67 0.59

Thyrocare Technologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Thyrocare Technologies's Scaled Net Operating Assets

For the Diagnostics & Research subindustry, Thyrocare Technologies's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thyrocare Technologies's Scaled Net Operating Assets Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Thyrocare Technologies's Scaled Net Operating Assets falls into.


;
;

Thyrocare Technologies Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Thyrocare Technologies's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2025 )
=(Operating Assets (A: Mar. 2025 )-Operating Liabilities (A: Mar. 2025 ))/Total Assets (A: Mar. 2024 )
=(4997.6-1210.2)/6438.8
=0.59

where

Operating Assets(A: Mar. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=6927.5 - 1929.9
=4997.6

Operating Liabilities(A: Mar. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1457 - 169.2 - 77.6
=1210.2

Thyrocare Technologies's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2025 )
=(Operating Assets (Q: Mar. 2025 )-Operating Liabilities (Q: Mar. 2025 ))/Total Assets (Q: Dec. 2024 )
=(4997.6-1210.2)/0
=N/A

where

Operating Assets(Q: Mar. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=6927.5 - 1929.9
=4997.6

Operating Liabilities(Q: Mar. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1457 - 169.2 - 77.6
=1210.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thyrocare Technologies Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Thyrocare Technologies Business Description

Traded in Other Exchanges
Address
D-37/3, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company majorly earns the majority of its revenue from the Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies Headlines

No Headlines